According to Cormedix's latest financial reports the company's current earnings (TTM) are -$46.34 M. In 2022 the company made an earning of -$30.29 M a decrease over its 2021 earnings that were of -$29.47 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$46.34 M | 53% |
2022 | -$30.29 M | 2.81% |
2021 | -$29.47 M | 8.32% |
2020 | -$27.2 M | 26.53% |
2019 | -$21.5 M | -19.89% |
2018 | -$26.83 M | -18.72% |
2017 | -$33.01 M | 34.56% |
2016 | -$24.54 M | 34.88% |
2015 | -$18.19 M | -11.08% |
2014 | -$20.46 M | 124.69% |
2013 | -$9.11 M | 144.91% |
2012 | -$3.72 M | -48.41% |
2011 | -$7.21 M | -33.29% |
2010 | -$10.81 M | 78.42% |
2009 | -$6.06 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | $1.54 B | -3,423.32% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $20.08 M | -143.35% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$0.65 B | 1,289.32% | ๐บ๐ธ USA |